Exelixis
EXEL
#1826
Rank
โ‚ฌ9.92 B
Marketcap
37,03ย โ‚ฌ
Share price
-1.20%
Change (1 day)
10.03%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company